Status:
UNKNOWN
Early-onset and Late-onset Sporadic Alzheimer's Disease (AD)
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
45-90 years
Phase:
NA
Brief Summary
Alzheimer's disease (AD) is usually associated with aging, age being the principal identified risk factor. However, younger subjects also develop AD and the prevalence of early onset AD is unknown. It...
Eligibility Criteria
Inclusion
- Arm Alzheimer Disease : first symptoms from 1 to 5 years before the inclusion, Clinical Dementia Rating = 1, efficient contraception for women
- Arm Control : efficient contraception for women
Exclusion
- Important general disease : diabetes, neoplasia, alcoholism
- First symptoms less than 1 year or more than 5 years before the inclusion
- Pregnancy, breast feeding
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00987090
Start Date
October 1 2009
Last Update
October 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique - Hôpitaux de Marseille
Marseille, France, France